ABCC1 and cholangiocarcinoma: In gemcitabine-resistant CCA cell lines, the overexpression of multidrug resistance-associated protein 1 (MRP1 or ABCC1) has been identified as a significant factor contributing to enhanced drug efflux and resistance [25].